title: Termination of second and early third trimester pregnancy: comparison of 3 methods.
abstract: The efficacy and safety of 3 methods used in legal termination of pregnancy in the second and early third trimester was assessed in 258 women in Jordan randomly assigned to receive Foley catheter (with and without traction) or prostaglandin E2 vaginal tablets. The failure rate of termination and the total insertion-to-termination time was higher with Foley catheter without traction (16.5%, 16.5 hours) than with traction (10.0%, 14.2 hours) or prostaglandin (8.0%, 11.5 hours). However, Foley catheter as a method of termination of pregnancy in second and early third trimester is safe and inexpensive, and its efficacy can be enhanced with the use of traction to give similar results to prostaglandin E2.
authors.affiliation: Department of Obstetrics and Gynaecology, King Hussein Medical Centre, Amman, Jordan. irshaid71@yahoo.com
authors.forename: I
authors.initials: I
authors.lastname: Bani-Irshaid
authors.forename: T Z
authors.initials: TZ
authors.lastname: Athamneh
authors.forename: D
authors.initials: D
authors.lastname: Bani-Khaled
authors.forename: M
authors.initials: M
authors.lastname: Al-Momani
authors.forename: H
authors.initials: H
authors.lastname: Dahamsheh
mesh_terms: D000019:Abortifacient Agents / Q000008:administration & dosage / Q000494:pharmacology; D000029:Abortion, Legal / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D000282:Administration, Intravaginal; D000328:Adult; D000704:Analysis of Variance; D002404:Catheterization / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D020070:Cervical Ripening / Q000187:drug effects / Q000502:physiology; D003362:Cost-Benefit Analysis; D015232:Dinoprostone / Q000008:administration & dosage / Q000494:pharmacology; D005260:Female; D006801:Humans; D007597:Jordan; D010120:Oxytocics / Q000008:administration & dosage / Q000494:pharmacology; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011263:Pregnancy Trimester, Third; D012449:Safety; D013607:Tablets; D013997:Time Factors; D014143:Traction / Q000009:adverse effects / Q000191:economics / Q000379:methods*; D016896:Treatment Outcome
chemical_list: D000019:Abortifacient Agents; D010120:Oxytocics; D013607:Tablets; D015232:Dinoprostone